[Skip to content]

Enter search here...
Worcestershire Health and Care NHS Trust
R&D banner

Our Performance Metrics

The Government aims to increase the number of patients who have the opportunity to participate in good quality research. 

To support this, the Department of Health has rolled out its assessment of the performance of NHS providers in setting up and recruiting patients to clinical trials. The Trust is required to publish its performance on a quarterly basis, both on its own internet pages and via the National Institute for Health Research Central Commissioning Facility.

The Trust is measured on two indicators; one is the time it has taken the Trust to start or 'initiate' a clinical trial, and the second is its delivery of commercial clinical research, to time and target.

Please click on the links below to see the studies the Trust has given NHS permission to since 1st April 2014.

Initiating Clinical Research: Quarter 1 (2019/20)

Clinical Research (commercial contract only): Quarter 1 (2019/20)


Clinical Trial: A set of medical research procedures conducted on human participants to allow safety and adverse effects 

of interventions, their efficacy, or their effectiveness to be established often by comparison with alternatives or placebo/sham interventions. Interventions may be drugs, diagnostics, prophylactics, surgery, devices, non-invasive therapies, screening or other healthcare procedures or technologies.

  • Clinical trial of an investigation medicinal product
  • Clinical investigation or other study of a medical device
  • Combined trial of an investigation medicinal product and an investigation medical device
  • Other clinical trial to study novel intervention or randomised clinical trial to compare interventions in clinical practice. 


Commercial Contract Clinical Trial: A clinical trial that is solely funded and sponsored by industry in which:

  •  The trial sponsor is the industrial company
  • The trial is carried out with the aim of generating data for purposes such as Marketing Authorisations, safety
  • monitoring and supportive evidence for claims
  • The sponsor owns all the trial data and all Intellectual Property and Know How arising directly from the trial.